Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Molecular and Clinical Oncology|August 9, 2020
Historical retrospective of the <b></b> oncogene and new perspectives (Review)Aristofania Simatou, George Simatos, Maria Goulielmaki, et al.
International Journal of Molecular Medicine|January 13, 2018
Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review)Marina Devetzi, Maria Goulielmaki, Nicolas Khoury, et al.
International Journal of Molecular Sciences|June 10, 2023
miRNA-Guided Regulation of Mesenchymal Stem Cells Derived from the Umbilical Cord: Paving the Way for Stem-Cell Based Regeneration and TherapyArsinoe C Thomaidou, Maria Goulielmaki, Antonis Tsintarakis, et al.
Molecular Medicine Reports|July 25, 2020
Significance of taurine transporter (TauT) in homeostasis and its layers of regulation (Review)Stella Baliou, Anthony M Kyriakopoulos, Maria Goulielmaki, et al.
International Journal of Molecular Medicine|February 4, 2021
Bromamine T, a stable active bromine compound, prevents the LPS‑induced inflammatory responseStella Baliou, Michael Sofopoulos, Maria Goulielmaki, et al.
International Journal of Molecular Sciences|July 28, 2022
Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAsArsinoe C Thomaidou, Panagiota Batsaki, Maria Adamaki, et al.
International Journal of Molecular Sciences|March 29, 2023
Frequencies of an Immunogenic HER-2/<i>neu</i> Epitope of CD8+ T Lymphocytes Predict Favorable Clinical Outcomes in Prostate CancerMaria Goulielmaki, Savvas Stokidis, Theodoros Anagnostou, et al.
Oncotarget|January 24, 2016
BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cellsMaria Goulielmaki, Evangelos Koustas, Eirini Moysidou, et al.
Oncology Letters|September 18, 2025
Novel biomarkers for prognosis in patients with localized prostate cancerMaria Goulielmaki, Savvas Stokidis, Theodoros Anagnostou, et al.
Cancers|January 12, 2021
Bromamine T (BAT) Exerts Stronger Anti-Cancer Properties than Taurine (Tau)Stella Baliou, Maria Goulielmaki, Petros Ioannou, et al.
Pageof 4